Posts for EDAP TMS SA ($EDAP)

Discover EDAP TMS S.A.'s impressive Q4 2024 preliminary results, featuring record Focal One sales and a 30% growth in U.S. prostate cancer procedures. Learn about future expectations and risks.

Explore EDAP TMS S.A.'s latest financial insights, including board member appointment, Focal One platform expansion, and strategic focus on HIFU technology applications.